Author Archives: admin

28 cool health things that started with a Canadian – Regina Leader-Post

By adminJuly 4, 2020Stem Cell Medicine

Alzheimers in mice

Dr. Peter St George-Hyslopof the Weston Brain Institute identified a number of genes responsible for Alzheimers disease and nerve cell degeneration using mouse models. He has published nearly 400 papers on Alzheimers research.

In the early 2000s, he essentially cured Alzheimers in mice through the discovery that certain types of sugars would block the development of amyloid proteins, one of the hallmarks of Alzheimers.

Genomics

University of Torontos Brenda Andrews pioneered the field of functional genomics and systems biology to discover how genes and their protein products regulate cell function in health and disease. She is also an elected member of the National Academy of Sciences and a specialist in the application of artificial intelligence to personalized medicine.

Kathleen Dickson is a former chief technician from the Montreal Neurological Institute.

John Bergeron is the Emeritus Robert Reford Professor and a Professor of Medicine at McGill University.

Dont miss the latest on COVID-19, reopening and life. Subscribe to Healthings daily newsletterComing Out of COVID.

Lungs in Vitro Market 2020 Opportunities, Growth Analysis, Trends and Forecast by 2024 | ATCC, Lonza, Epithelix – 3rd Watch News

By adminJuly 4, 2020Stem Cell Medicine

Competitive Market Research Report on Global Lungs in Vitro Market with focus on Industry Analysis, Growth Opportunities, Risk Analysis, Current Trends, Competitive Landscape, Investment Strategies and Forecast by 2024.

The report contains in-depth information on all the key aspects of the global Lungs in Vitro market. This report contains important data such as facts & figures, market research, market analysis, SWOT analysis, competitive landscape, regional analysis and future growth prospects. The report also contains qualitative and quantitative research which gives you a detailed analysis of the global Lungs in Vitro market. The report is perfect as you can see information on the recent developments, based on which you can make risk assessments and investments in the Lungs in Vitro industry.

Get The Sample Report PDF with Detail TOC & List of [emailprotected]https://marketresearchport.com/request-sample/5147

Leading Companies Covered:

ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero, Cn Bio

This global Lungs in Vitro market research report has data of all the leading players operating in the industry. From their market shares in the industry, to their growth plans, recent development status, all important information has been compiled in the report to let you get an insightful look at the top players operating in the industry. The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.

Market Research is Further Divided into Following Segments:

Market Segmentation by Product Types: 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, Inhouse 3D Cell Models

Market Segmentation by Applications: Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine

Regions Mentioned in the Global Lungs in Vitro Market:

The Middle East and Africa North America South America Europe Asia-Pacific Middle East Oceania Rest of the World

The data of the market research report has been studied, compiled and corroborated by leading industry experts and established authors. The format followed in the report is in accordance with most international market research reports. However, if you have any specific requirements, just get in touch with us, and we will customize the report accordingly as per your needs.

Do Enquiry For Customized Report as per Your [emailprotected]https://marketresearchport.com/enquiry-before-buying/5147

Table of Content: 1 Industry Overview of Lungs in Vitro 1.1 Brief Introduction of Lungs in Vitro 1.1.1 Definition of Lungs in Vitro 1.1.2 Development of Lungs in Vitro Industry 1.2 Classification of Lungs in Vitro 1.3 Status of Lungs in Vitro Industry 1.3.1 Industry Overview of Lungs in Vitro 1.3.2 Global Major Regions Status of Lungs in Vitro

2 Industry Chain Analysis of Lungs in Vitro 2.1 Supply Chain Relationship Analysis of Lungs in Vitro 2.2 Upstream Major Raw Materials and Price Analysis of Lungs in Vitro 2.3 Downstream Applications of Lungs in Vitro

3 Manufacturing Technology of Lungs in Vitro 3.1 Development of Lungs in Vitro Manufacturing Technology 3.2 Manufacturing Process Analysis of Lungs in Vitro 3.3 Trends of Lungs in Vitro Manufacturing Technology

4 Major Manufacturers Analysis of Lungs in Vitro 4.1 Company 1 4.1.1 Company Profile 4.1.2 Product Picture and Specifications 4.1.3 Capacity, Production, Price, Cost, Gross and Revenue 4.1.4 Contact Information 4.2 Company 2 4.2.1 Company Profile 4.2.2 Product Picture and Specifications 4.2.3 Capacity, Production, Price, Cost, Gross and Revenue 4.2.4 Contact Information 4.3 Company 3 4.3.1 Company Profile 4.3.2 Product Picture and Specifications 4.3.3 Capacity, Production, Price, Cost, Gross and Revenue 4.3.4 Contact Information 4.4 Company 4 4.4.1 Company Profile 4.4.2 Product Picture and Specifications 4.4.3 Capacity, Production, Price, Cost, Gross and Revenue 4.4.4 Contact Information 4.5 Company 5 4.5.1 Company Profile 4.5.2 Product Picture and Specifications 4.5.3 Capacity, Production, Price, Cost, Gross and Revenue 4.5.4 Contact Information 4.6 Company 6 4.6.1 Company Profile 4.6.2 Product Picture and Specifications 4.6.3 Capacity, Production, Price, Cost, Gross and Revenue 4.6.4 Contact Information 4.7 Company 7 4.7.1 Company Profile 4.7.2 Product Picture and Specifications 4.7.3 Capacity, Production, Price, Cost, Gross and Revenue 4.7.4 Contact Information 4.8 Company 8 4.8.1 Company Profile 4.8.2 Product Picture and Specifications 4.8.3 Capacity, Production, Price, Cost, Gross and Revenue 4.8.4 Contact Information 4.9 Company 9 4.9.1 Company Profile 4.9.2 Product Picture and Specifications 4.9.3 Capacity, Production, Price, Cost, Gross and Revenue 4.9.4 Contact Information 4.10 Company ten 4.10.1 Company Profile 4.10.2 Product Picture and Specifications 4.10.3 Capacity, Production, Price, Cost, Gross and Revenue 4.10.4 Contact Information

5 Global Productions, Revenue and Price Analysis of Lungs in Vitro by Regions, Manufacturers, Types and Applications 5.1 Global Production, Revenue of Lungs in Vitro by Regions 2014-2019 5.2 Global Production, Revenue of Lungs in Vitro by Manufacturers 2014-2019 5.3 Global Production, Revenue of Lungs in Vitro by Types 2014-2019 5.4 Global Production, Revenue of Lungs in Vitro by Applications 2014-2019 5.5 Price Analysis of Global Lungs in Vitro by Regions, Manufacturers, Types and Applications in 2014-2019

6 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Lungs in Vitro 2014-2019 6.1 Global Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019 6.2 Asia Pacific Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019 6.3 Europe Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019 6.4 Middle East & Africa Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019 6.5 North America Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019 6.6 Latin America Capacity, Production, Price, Cost, Revenue, of Lungs in Vitro 2014-2019

7 Consumption Volumes, Consumption Value, Import, Export and Sale Price Analysis of Lungs in Vitro by Regions 7.1 Global Consumption Volume and Consumption Value of Lungs in Vitro by Regions 2014-2019 7.2 Global Consumption Volume, Consumption Value and Growth Rate of Lungs in Vitro 2014-2019 7.3 Asia Pacific Consumption Volume, Consumption Value, Import, Export and Growth Rate of Lungs in Vitro 2014-2019 7.4 Europe Consumption Volume, Consumption Value, Import, Export and Growth Rate of Lungs in Vitro 2014-2019 7.5 Middle East & Africa Consumption Volume, Consumption Value, Import, Export and Growth Rate of Lungs in Vitro 2014-2019 7.6 North America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Lungs in Vitro 2014-2019 7.7 Latin America Consumption Volume, Consumption Value, Import, Export and Growth Rate of Lungs in Vitro 2014-2019 7.8 Sale Price Analysis of Global Lungs in Vitro by Regions 2014-2019

8 Gross and Gross Margin Analysis of Lungs in Vitro 8.1 Global Gross and Gross Margin of Lungs in Vitro by Regions 2014-2019 8.2 Global Gross and Gross Margin of Lungs in Vitro by Manufacturers 2014-2019 8.3 Global Gross and Gross Margin of Lungs in Vitro by Types 2014-2019 8.4 Global Gross and Gross Margin of Lungs in Vitro by Applications 2014-2019

9 Marketing Traders or Distributor Analysis of Lungs in Vitro 9.1 Marketing Channels Status of Lungs in Vitro 9.2 Marketing Channels Characteristic of Lungs in Vitro 9.3 Marketing Channels Development Trend of Lungs in Vitro

10 Global and Chinese Economic Impacts on Lungs in Vitro Industry 10.1 Global and Chinese Macroeconomic Environment Analysis 10.1.1 Global Macroeconomic Analysis and Outlook 10.1.2 Chinese Macroeconomic Analysis and Outlook 10.2 Effects to Lungs in Vitro Industry

11 Development Trend Analysis of Lungs in Vitro 11.1 Capacity, Production and Revenue Forecast of Lungs in Vitro by Regions, Types and Applications 11.1.1 Global Capacity, Production and Revenue of Lungs in Vitro by Regions 2019-2024 11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Lungs in Vitro 2019-2024 11.1.3 Global Capacity, Production and Revenue of Lungs in Vitro by Types 2019-2024 11.2 Consumption Volume and Consumption Value Forecast of Lungs in Vitro by Regions 11.2.1 Global Consumption Volume and Consumption Value of Lungs in Vitro by Regions 2019-2024 11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Lungs in Vitro 2019-2024 11.3 Supply, Import, Export and Consumption Forecast of Lungs in Vitro 11.3.1 Supply, Consumption and Gap of Lungs in Vitro 2019-2024 11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024 11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024 11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024 11.3.5 Asia Pacific Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024 11.3.6 Middle East & Africa Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024 11.3.7 Latin America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Lungs in Vitro 2019-2024

12 Contact information of Lungs in Vitro 12.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Lungs in Vitro 12.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Lungs in Vitro 12.1.2 Major Equipment Suppliers with Contact Information Analysis of Lungs in Vitro 12.2 Downstream Major Consumers Analysis of Lungs in Vitro 12.3 Major Suppliers of Lungs in Vitro with Contact Information 12.4 Supply Chain Relationship Analysis of Lungs in Vitro

13 New Project Investment Feasibility Analysis of Lungs in Vitro 13.1 New Project SWOT Analysis of Lungs in Vitro 13.2 New Project Investment Feasibility Analysis of Lungs in Vitro 13.2.1 Project Name 13.2.2 Investment Budget 13.2.3 Project Product Solutions 13.2.4 Project Schedule

14 Conclusion of the Global Lungs in Vitro Industry 2019 Market Research Report

About Us: Market Research Port is one of the best report resellers in the market bringing to you accurate and trustworthy market research reports by reputed publishers. Our trusted publishers have compiled their reports and findings after painstaking research and studies, set up against varied business parameters. Each report is detailed and then vetted for accuracy by industry experts. In each report, you will find deep analysis, risk analysis, market forecasts, emerging trends, different market segments, technological advancement and its impact, and a multitude of economic factors, giving you the most comprehensive market research report. You get many advantages with such comprehensive reports.

Contact Us: Market Research Port, Brighton Street, Providence, Rhode Island 02929, United States Contact No: +1 401 433 7610 Email: [emailprotected] Website: https://marketresearchport.com/

See the original post here:
Lungs in Vitro Market 2020 Opportunities, Growth Analysis, Trends and Forecast by 2024 | ATCC, Lonza, Epithelix - 3rd Watch News

How COVID-19 Pandemic Will Impact Australia & New Zealand Research Antibodies Market Business Opportunity, And Growth 2020-2026 – 3rd Watch News

By adminJuly 4, 2020Stem Cell Medicine

Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Australia & New Zealand Research Antibodies market.

Trusted Business Insights presents an updated and Latest Study on Australia & New Zealand Research Antibodies Market 2019-2026. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market.The report further elaborates on the micro and macroeconomic aspects including the socio-political landscape that is anticipated to shape the demand of the Australia & New Zealand Research Antibodies market during the forecast period (2019-2029). It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.

Get Sample Copy of this Report @ Australia & New Zealand Research Antibodies Market Size Report, 2026 (Includes Business Impact of COVID-19)

Industry Insights, Market Size, CAGR, High-Level Analysis: Australia & New Zealand Research Antibodies Market

The Australia & New Zealand research antibodies market size was valued at USD 98.4 million in 2018 and is anticipated to grow at a CAGR of 8.4% during the forecast period. Rise in the number of initiatives being undertaken by the Australian government to advance the biotechnology sector is expected to fuel the growth in the country. In May 2019, Federal Labor offered businesses an R&D tax offset for collaborating with science-based agencies and universities, such as The Commonwealth Scientific and Industrial Research Organisation (CSIRO), to promote innovation and knowledge in biotechnology sector. In addition, a 10% tax can be added to the calculated tax offset if a business is collaborating with any public institution. This plan would help in increasing R&D investments in Australia to 3% of GDP by 2030 and is expected to act as a key tool for fostering an alliance between research and industry, thereby improving industrial capabilities in Australia. R&D tax incentive in Australia has encouraged biotechnology companies in the region to conduct R&D. For instance, in 2018, Shape Pharmaceuticals, Inc. supported R&D investments in Australian biotechnology industry by conducting clinical trials to study the effect of SHP-141 on patients diagnosed with psoriasis. These tax incentives help companies achieve cost advantage while selecting clinical trial sites for R&D processes.

Rise in R&D investments by the government is also expected to boost the market. In 2018, the Victorian government allocated USD 1.5 million for establishment of an Advanced Biotechnology Manufacturing Platform to enhance production of antibodies, vaccines, stem cells, and growth factors, among others, for testing in human clinical trials. This facility would enable various Australian biotechnology companies to conduct R&D in the state, thereby generating jobs and propelling growth of various companies currently conducting clinical trials in Victoria. The government is also promoting development of the biotechnology sector through Future Industries Fund. Growth in stem cell and neurobiology-based research is expected to boost the market over the forecast period. The Center of Research Excellence in Neuromuscular Disorders Australia is a wide collaboration of neuromuscular experts, who use advanced technologies and approaches in science & medicine to improve diagnosis. In addition, it aims to transform treatment to effective therapy of neurological diseases from compassionate management. The Australian Neuromuscular Network was formed in the year 2010 by the Center of Research Excellence in Neuromuscular Disorders along with other neuromuscular specialists, scientists, and professionals across New Zealand and Australia. Rise in the prevalence of neurological disorders is expected to boost the market. According to the Neurological Foundation of New Zealand, by 2051, about one-third of the population in New Zealand will be 65 years and above. The prevalence of dementia is therefore expected to increase, leading to a rise in R&D pertaining to treatment for various neurological disorders. However, stringent government regulations that can limit research activities are expected to restrain market growth.

Product Insights of Australia & New Zealand Research Antibodies Market

On basis of product, Australia & New Zealand research antibodies market is segmented into primary and secondary antibodies. Primary antibodies held the largest share and is anticipated to witness the highest CAGR owing to rise in adoption of reagents developed using antibodies, due to the various benefits associated with them such as greater specificity, easy availability, and suitability in various research applications. Similarly, primary antibodies are anticipated to grow at a faster rate during the forecast period due to varied applications in research. In addition, rise in prevalence of chronic diseases, such as diabetes, cancer, and Alzheimers disease, is leading to an increase in adoption of primary antibodies. Increasing R&D in the country is further anticipated to boost the adoption of secondary antibodies as well. Thus, rising adoption of these antibodies in research for development of alternative therapies is anticipated to create significant demand for these products over the forecast period. End-use Insights Pharmaceutical & biotechnology companies held the largest share of the end-use segment in 2018, which can be attributed to increase in adoption of antibodies in drug development and research organizations. Contract research organizations are anticipated to grow at a lucrative CAGR during the forecast period owing to cost-effectiveness.

The academic & research institutes segment is expected to witness constant growth owing to the presence of various academic research groups that are involved in the study of complex biological systems using advanced reagents. Benefits such as greater understanding of biological processes and complex systems are anticipated to create growth opportunities in the segment. Contract research organizations are anticipated to grow at a lucrative CAGR during the forecast period. Majority of the companies prefer CROs owing to the various advantages associated with contract services. These benefits include cost advantage, increased efficiency of services, and enhanced productivity, which help a company focus on its core expertise.

Type Insights of Australia & New Zealand Research Antibodies Market

On the basis of antibody type, the market is segmented into monoclonal and polyclonal antibodies. Monoclonal antibodies held the largest market share due to increase in research on genomics and personalized medicine, which has led to increase in the use of these antibodies. As monoclonal antibodies are relatively cost-effective, they are anticipated to grow at a higher rate than polyclonal antibodies. Polyclonal antibodies have several advantages over monoclonal in various diagnostic settings. Polyclonal antibodies are often the most preferred option in routine laboratory tests such as Enzyme-Linked Immunosorbent Assay (ELISA), microarray assays, western blotting, flow cytometry, and immunohistochemistry. Their production does not require skilled professionals, and large batches can be produced as per client requirements. These antibodies can recognize multiple antigens on one epitope and can therefore be utilized in the study of various diseases ranging from cancer to metabolic Polyclonal antibodies are relatively inexpensive in comparison with monoclonal antibodies, which may fuel their demand in low-budget and non-funded research projects. However, polyclonal antibodies can differ from batch to batch depending upon manufacturing and quality control process. These antibodies can recognize multiple epitopes, thus increasing the probability of nonspecific antigen binding.

Technology Insights of Australia & New Zealand Research Antibodies Market

On the basis of technology, the Australia & New Zealand research antibodies market is segmented into western blotting, immunoprecipitation, immunochemistry, ELISA, immunofluorescence, flow cytometry, and other technologies. Western blotting held the largest share of the technology segment in 2018 owing to rising demand for rapid diagnostic methods. On the other hand, technical upgradation is anticipated to create growth prospects for technologies in pipeline. ELISA is anticipated to witness the highest CAGR during the forecast period owing to conventional use of polyclonal antibodies in sandwich ELISA. ELISA is an analytical test that essentially uses antibodies to identify substances in samples. These tests are most often used to accurately diagnose diseases, such as AIDS, Lyme disease, syphilis, pernicious anemia, Rocky Mountain spotted fever, squamous cell carcinoma, chickenpox, shingles, and other bacterial & viral infections. Western blotting held the largest share in 2018 owing to rise in prevalence of diseases with limited number of treatment options. Western blotting offers high accuracy and sensitivity and is considered a gold standard for testing. In addition, increase in government initiatives to fund research activities is one of the factors contributing to the highest market share held by this segment, as it is conventionally used in research laboratories. Source Insights The mouse segment held the largest share in 2018 as mice are convenient to use during production of antibodies for research purposes and have wide range of applications. Others segment is expected to grow exponentially, as it has a wide range of applications. The use of murine monoclonal antibodies is increasing in various end-use settings, which is expected to positively impact market growth. Mice have been predominantly used in production of antibodies. The structural similarities in mice and human antibodies is a prime factor responsible for high adoption. Cost-effectiveness and the ability to multiply quickly are among the factors fueling growth of this segment. Moreover, mouse-derived monoclonal and polyclonal antibodies are relatively easier to produce and possess greater specificity. Technological advancements in the development processes of these products, such as hybridoma technology that aids in production of monoclonal antibodies in specialized cells, are further augmenting demand for mouse antibodies. Rabbits are also extensively used for production of antibodies, owing to various advantages such as higher affinity and specificity in comparison with antisera obtained from other animal hosts. Higher specificity of these products makes them ideal for use in detection of small molecules, such as pollutants; toxins; hormones; drugs; nonprotein targets, such as carbohydrates & lipids; and post-translational alterations such as phosphorylation.

Application Insights of Australia & New Zealand Research Antibodies Market

Oncology held the largest share of the application segment in 2018. The largest share can be attributed to growing prevalence of cancer, which leads to an increase in the need for R&D pertaining to advanced therapeutics. On the other hand, stem cell is anticipated to witness lucrative CAGR during the forecast period owing to significant increase in stem cells research. Rising prevalence of infectious diseases, growing geriatric population, decreasing immunity levels, and rising awareness among people about communicable diseases are some of the high impact-rendering drivers of the market. Growing incidence of autoimmune diseases coupled with limited presence of advanced therapeutics is predominantly driving segment growth. Significant advancements in immunology research have boosted adoption of research antibodies in the recent years. Oncology accounted for the largest share of research antibodies in 2018.The segment is also anticipated to grow at a considerable CAGR owing to increasing incidence of cancer. According to WHO, the number of new cancer cases is anticipated to increase by approximately 70.0% in the next two decades. Monoclonal antibodies are also used for diagnosis of lymphoid & myeloid malignancies, tissue typing, and immunological intervention using passive antibody. Owing to the steady increase in the demand for transplantable tissues and low-quality donor cells, stem cell research segment is expected to grow. Moreover, increasing adoption of cell isolation and culture, which involves use of research antibodies, is further anticipated to broaden segment growth prospects.

Market Share Insights of Australia & New Zealand Research Antibodies Market

Some major players in this market are PerkinElmer, Inc.; F.Hoffmann La Roche Ltd.; Thermo Fisher Scientific; Merck Millipore; Bio-Rad Laboratories; Abcam PLC; BD; Lonza Group; Cell Signaling Technology, Inc.; and Agilent Technologies. Increase in the number of products launched by market players is expected to fuel market growth. For instance, in April 2019, Bio-Rad launched a range of isotype-specific secondary antibodies-IgG1, IgG2a, and IgG2b. These products are used to offer specificity when used in ELISA, imaging, western blotting, and flow cytometry, among others, as well as for improved signaling. Mergers & acquisitions and collaborations are some of the other strategic initiatives undertaken by leading players to gain market share, for instance, Abcam Plc acquired Calico Biolabs. This initiative helped the company expand its product portfolio through the addition of high-quality recombinant rabbit monoclonal antibodies for immunohistochemistry. As per the agreement, Abcam was to also expand its custom rabbit monoclonal antibody production. These factors are further anticipated to aid growth during the forecast period.

Segmentations, Sub Segmentations, CAGR, & High-Level Analysis overview of Australia & New Zealand Research Antibodies Market Research Report This report forecasts revenue growth at country level and provides an analysis on the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, this market research report has segmented the Australia & New Zealand research antibodies market report on the basis of product, type, technology, source application, end use, and country:

Product Outlook (Revenue, USD Million, 2019 2030)

Primary

Secondary

Type Outlook (Revenue, USD Million, 2019 2030)

Monoclonal Antibodies

Polyclonal Antibodies

Technology Outlook (Revenue, USD Million, 2019 2030)

Immunohistochemistry

Immunofluorescence

Western Blotting

Flow Cytometry

Immunoprecipitation

ELISA

Others

Source Outlook (Revenue, USD Million, 2019 2030)

Mouse

Rabbit

Goat

Others

Application Outlook (Revenue, USD Million, 2019 2030)

Infectious Diseases

Immunology

Oncology

Stem Cells

Neurobiology

Others

End-use Outlook (Revenue, USD Million, 2019 2030)

Academic & Research Institutes

Contract Research Organizations

Pharmaceutical & Biotechnology Companies

Quick Read Table of Contents of this Report @ Australia & New Zealand Research Antibodies Market Size Report, 2026 (Includes Business Impact of COVID-19)

Trusted Business Insights Shelly Arnold Media & Marketing Executive Email Me For Any Clarifications Connect on LinkedIn Click to follow Trusted Business Insights LinkedIn for Market Data and Updates. US: +1 646 568 9797 UK: +44 330 808 0580

See the article here:
How COVID-19 Pandemic Will Impact Australia & New Zealand Research Antibodies Market Business Opportunity, And Growth 2020-2026 - 3rd Watch News

Stem Cell Therapy Market to 2027 Global Analysis and Forecast by Type, Treatment, End User – Apsters News

By adminJuly 3, 2020Stem Cell Clinic

Stem Cell Therapy Market Insights 2020

Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management

Stem cell research has been widely investigated globally to enhance human health in a medical setting. For this, creating public awareness about stem cell research is vital for realizing this potential. The stem cells main role is to replace dying cells and reconstruct damaged tissues. Based on the extensive stem cell research results, many scientists have claimed that the cells could probably generate cures and treatment for various diseases, including cancers, cardiovascular disease, and others. Newly developed stem cell therapies having the capability to replace disease, causing cells. Hence, patients now started relying on stem cell therapy that has long term positive outcomes. There is an increasing number of potential treatments that are undergoing in clinical trials phase. The FDA has approved very few stem cell therapies. For instance, in 2019, Fedratinib, approved by the FDA for the first-line treatment for fibrosis. Bone marrow transplantation is widely used stem cell based therapy. Blood forming stem cells were the first to be used in the clinic. This stem cell therapy has benefited thousands of patients who have leukemia.

Download sample PDF copy at:https://www.theinsightpartners.com/sample/TIPHE100000991/

Strategic Insights

Product launches and FDA approvals strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the stem cell therapy market adopt the strategy of collaborations to enlarge customer base across the world, which also permits the players to maintain their brand name globally.

Company Profiles

The stem cell therapy market is expected to grow, owing to factors such Increasing awareness related to the stem cells therapy in effective disease management, growing demand for regenerative medicines, and growing cancer prevalence across the globe are likely to have a positive impact on the growth of the market in coming years.

Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPHE100000991/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Call: +1-646-491-9876

Email: [emailprotected]

Continued here:
Stem Cell Therapy Market to 2027 Global Analysis and Forecast by Type, Treatment, End User - Apsters News

COVID-19 Update: Global Cancer Stem Cell Therapy Market is Expected to Grow at a Healthy CAGR with top players AVIVA BioSciences, AdnaGen, Advanced…

By adminJuly 3, 2020Stem Cell Clinic

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Cancer Stem Cell TherapyMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Cancer Stem Cell Therapy Market Players to battle Covid-19 Impact.

Theglobal Cancer Stem Cell Therapy market has been remarkable momentum in the recent years. The Cancer Stem Cell TherapyMarket report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Cancer Stem Cell Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Cancer Stem Cell Therapy market.

Top Leading players covered in the Cancer Stem Cell Therapy market report: AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics, Silicon Biosystems and More

Get PDF Sample Report With Impact of COVID-19 on Cancer Stem Cell Therapy [emailprotected] https://www.marketinforeports.com/Market-Reports/Request-Sample/98333

The Cancer Stem Cell Therapy market report specifically highlights the market share, regional outlook, company profiles, product portfolio, a record of the recent developments, strategic analysis, AVIVA BioSciences, AdnaGen, Advanced Cell Diagnostics, Silicon Biosystems in the market, sales, distribution chain, manufacturing, production, new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the market to help the new entrants understand the market scenario better. the global Cancer Stem Cell Therapy market will showcase a steady CAGR in the forecast year 2020 to 2026.

Market Segment by Type covers: Autologous Stem Cell Transplants Allogeneic Stem Cell Transplants Syngeneic Stem Cell Transplants Others

Market Segment by Application covers: Hospital Clinic Medical Research Institution Others

Our Complimentary Sample Cancer Stem Cell Therapy market Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% DiscountBy Clicking Here! https://www.marketinforeports.com/Market-Reports/Request_discount/98333

Regions Covered in the Global Cancer Stem Cell Therapy Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Cancer Stem Cell Therapy Market Size: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year: 2020-2026

Highlights of the Report: Accurate market size and CAGR forecasts for the period 2019-2026 Identification and in-depth assessment of growth opportunities in key segments and regions Detailed company profiling of top players of the global Cancer Stem Cell Therapy market Exhaustive research on innovation and other trends of the global Cancer Stem Cell Therapy market Reliable industry value chain and supply chain analysis Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For More Information:https://www.marketinforeports.com/Market-Reports/98333/Cancer-Stem-Cell-Therapy-market

Customization of the Report: Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]: https://www.marketinforeports.com/Market-Reports/Request-Customization/98333/Cancer-Stem-Cell-Therapy-market

Contact Us: Mr. Marcus Kel Call: +1 415 658 9988 (International) +91 84 839 65921 (IND) Email: [emailprotected] Website: http://www.marketinforeports.com

Choroideremia Treatment Market to Eyewitness Massive Growth by 2026 | Biogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc – Jewish Life…

By adminJuly 3, 2020Gene Therapy Clinics

Global Choroideremia Treatment Market By Treatment Type (Gene Therapy, Surgery), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Ophthalmic Clinics and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Forecast to 2026

Global Choroideremia Treatment Marketis expected to grow at a steady CAGR in the forecast period of 2019-2026.Increase in strategic alliances between the pharmaceuticals companies and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Some of the major competitors currently working in the global choroideremia treatment market areBiogen, 4D Molecular Therapeutics, Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION, Retina Implant AG, F. Hoffmann-La Roche Ltd and others.

Download exclusive PDF sample report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-choroideremia-treatment-market

Market Definition:

Choroideremia is also known as choroidal sclerosis is a rare, degenerative, X-linked inherited retinal disorder characterized by progressive degeneration of the choroid, retinal pigment epithelium (RPE) and retina due to Mutations in the CHM gene. This CHM gene required to produce Rab escort protein-1 (REP-1). The condition gets its name from the distinctive sweet odor of affected infants urine and is also c, a protein that takes part in targeting vesicles (small sacs of substances) into, out of, and within cells.

According to the statistics published by U.S. Department of Health & Human Services, an estimated population of choroideremia is about 1 in 50,000-100,000 people. Presence of refined healthcare infrastructure and emerging new market are the key factors for growth of this market.

Market Drivers

Market Restraints

Segmentation:Global Choroideremia Treatment Market

By Treatment

By Route of Administration

By End Users

By Distribution Channel

ByGeography

Download Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-choroideremia-treatment-market

Key Developments in the Market:

Competitive Analysis:

Global choroideremia treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global choroideremia treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Order a Copy of Global Choroideremia Treatment Market Report @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-choroideremia-treatment-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Trending: Precision Cancer Therapies Growth by Top Companies, Trends by Types and Application, Forecast to 2026 | Abbott Laboratories, Bayer…

By adminJuly 3, 2020Gene Therapy Clinics

LOS ANGELES, United States: QY Research has recently published a report, titled Global Precision Cancer Therapies Market Size, Status and Forecast 2020-2026. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Precision Cancer Therapies market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.

Key Companies/Manufacturers operating in the global Precision Cancer Therapies market include: Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca, Aveo Pharmaceuticals Precision Cancer Therapies

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1910677/global-precision-cancer-therapies-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Precision Cancer Therapies market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Precision Cancer Therapies Market Segment By Type:

Hormone Therapy Immunotherapies Targeted Therapy Monoclonal Antibody Therapy Gene Therapy Precision Cancer Therapies

Global Precision Cancer Therapies Market Segment By Application:

Hospitals Diagnostic Centers Oncology Clinics Research Institutes

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Precision Cancer Therapies market.

Key companies operating in the global Precision Cancer Therapies market include Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca, Aveo Pharmaceuticals Precision Cancer Therapies

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1910677/global-precision-cancer-therapies-market

TOC

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Precision Cancer Therapies Revenue 1.4 Market by Type 1.4.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hormone Therapy 1.4.3 Immunotherapies 1.4.4 Targeted Therapy 1.4.5 Monoclonal Antibody Therapy 1.4.6 Gene Therapy 1.5 Market by Application 1.5.1 Global Precision Cancer Therapies Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Diagnostic Centers 1.5.4 Oncology Clinics 1.5.5 Research Institutes 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Precision Cancer Therapies Market Perspective (2015-2026) 2.2 Global Precision Cancer Therapies Growth Trends by Regions 2.2.1 Precision Cancer Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Precision Cancer Therapies Historic Market Share by Regions (2015-2020) 2.2.3 Precision Cancer Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porters Five Forces Analysis 2.3.5 Precision Cancer Therapies Market Growth Strategy 2.3.6 Primary Interviews with Key Precision Cancer Therapies Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Precision Cancer Therapies Players by Market Size 3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2015-2020) 3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2015-2020) 3.1.3 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Precision Cancer Therapies Market Concentration Ratio 3.2.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2019 3.3 Precision Cancer Therapies Key Players Head office and Area Served 3.4 Key Players Precision Cancer Therapies Product Solution and Service 3.5 Date of Enter into Precision Cancer Therapies Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Precision Cancer Therapies Historic Market Size by Type (2015-2020) 4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Precision Cancer Therapies Market Size by Application (2015-2020) 5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Precision Cancer Therapies Market Size (2015-2020) 6.2 Precision Cancer Therapies Key Players in North America (2019-2020) 6.3 North America Precision Cancer Therapies Market Size by Type (2015-2020) 6.4 North America Precision Cancer Therapies Market Size by Application (2015-2020) 7 Europe 7.1 Europe Precision Cancer Therapies Market Size (2015-2020) 7.2 Precision Cancer Therapies Key Players in Europe (2019-2020) 7.3 Europe Precision Cancer Therapies Market Size by Type (2015-2020) 7.4 Europe Precision Cancer Therapies Market Size by Application (2015-2020) 8 China 8.1 China Precision Cancer Therapies Market Size (2015-2020) 8.2 Precision Cancer Therapies Key Players in China (2019-2020) 8.3 China Precision Cancer Therapies Market Size by Type (2015-2020) 8.4 China Precision Cancer Therapies Market Size by Application (2015-2020) 9 Japan 9.1 Japan Precision Cancer Therapies Market Size (2015-2020) 9.2 Precision Cancer Therapies Key Players in Japan (2019-2020) 9.3 Japan Precision Cancer Therapies Market Size by Type (2015-2020) 9.4 Japan Precision Cancer Therapies Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Precision Cancer Therapies Market Size (2015-2020) 10.2 Precision Cancer Therapies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Precision Cancer Therapies Market Size by Type (2015-2020) 10.4 Southeast Asia Precision Cancer Therapies Market Size by Application (2015-2020) 11 India 11.1 India Precision Cancer Therapies Market Size (2015-2020) 11.2 Precision Cancer Therapies Key Players in India (2019-2020) 11.3 India Precision Cancer Therapies Market Size by Type (2015-2020) 11.4 India Precision Cancer Therapies Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Precision Cancer Therapies Market Size (2015-2020) 12.2 Precision Cancer Therapies Key Players in Central & South America (2019-2020) 12.3 Central & South America Precision Cancer Therapies Market Size by Type (2015-2020) 12.4 Central & South America Precision Cancer Therapies Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott Laboratories 13.1.1 Abbott Laboratories Company Details 13.1.2 Abbott Laboratories Business Overview 13.1.3 Abbott Laboratories Precision Cancer Therapies Introduction 13.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2015-2020)) 13.1.5 Abbott Laboratories Recent Development 13.2 Bayer HealthCare 13.2.1 Bayer HealthCare Company Details 13.2.2 Bayer HealthCare Business Overview 13.2.3 Bayer HealthCare Precision Cancer Therapies Introduction 13.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2015-2020) 13.2.5 Bayer HealthCare Recent Development 13.3 GlaxoSmithKline 13.3.1 GlaxoSmithKline Company Details 13.3.2 GlaxoSmithKline Business Overview 13.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction 13.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2015-2020) 13.3.5 GlaxoSmithKline Recent Development 13.4 OncoGenex Pharmaceuticals 13.4.1 OncoGenex Pharmaceuticals Company Details 13.4.2 OncoGenex Pharmaceuticals Business Overview 13.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction 13.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020) 13.4.5 OncoGenex Pharmaceuticals Recent Development 13.5 Hospira 13.5.1 Hospira Company Details 13.5.2 Hospira Business Overview 13.5.3 Hospira Precision Cancer Therapies Introduction 13.5.4 Hospira Revenue in Precision Cancer Therapies Business (2015-2020) 13.5.5 Hospira Recent Development 13.6 Boehringer Ingelheim 13.6.1 Boehringer Ingelheim Company Details 13.6.2 Boehringer Ingelheim Business Overview 13.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction 13.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2015-2020) 13.6.5 Boehringer Ingelheim Recent Development 13.7 AstraZeneca 13.7.1 AstraZeneca Company Details 13.7.2 AstraZeneca Business Overview 13.7.3 AstraZeneca Precision Cancer Therapies Introduction 13.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2015-2020) 13.7.5 AstraZeneca Recent Development 13.8 Aveo Pharmaceuticals 13.8.1 Aveo Pharmaceuticals Company Details 13.8.2 Aveo Pharmaceuticals Business Overview 13.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction 13.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2015-2020) 13.8.5 Aveo Pharmaceuticals Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

The rest is here:
Trending: Precision Cancer Therapies Growth by Top Companies, Trends by Types and Application, Forecast to 2026 | Abbott Laboratories, Bayer...

College Kids Are Apparently Playing a Game Where They Try to Catch COVID – Futurism

By adminJuly 3, 2020Stem Cell Doctors

The coronavirus that causes COVID-19 can be deadly, even to young people, with estimates of its overall mortality rate often hovering around one percent.

But according to a city official in Tuscaloosa, Alabama, that isnt stopping college students from arranging COVID-19 parties. She says that infected students attend the parties, which charge an entry fee, and then the first attendee to be diagnosed with COVID by a doctor gets the cash.

They put money in a pot and they try to get COVID, City Council member Sonya McKinstry said during a recent city meeting, according to ABC News. Whoever gets COVID first gets the pot. It makes no sense. Theyre intentionally doing it.

Tuscaloosa fire chief Randy Smith corroborated McKinstrys claims at the same meeting.

We thought that was kind of a rumor at first, he said, according to ABC. We did some research. Not only do the doctors offices confirm it but the state confirmed they also had the same information.

Neither official named a specific college in their claims, though Tuscaloosa is home to a number of schools including the University of Alabama and Stillman College. The coronavirus has killed nearly 1,000 people in Alabama.

CNN later caught up with McKinstry, who doubled down on the intel about the parties and decried the risky behavior, which flies in the face of common sense and public health.

It makes me furious, McKinstry said, according to CNN. Furious to the fact that something that is so serious and deadly is being taken for granted. Not only is it irresponsible, but you could contract the virus and take it home to your parents or grandparents.

Even with two officials corroborating the party story, its possible the gatherings are a rumor. Theres a long history of moral panics sweeping the United States before it ultimately turns out that actual phenomenon was rare or nonexistent.

In the case of the COVID parties, other city officials were evasive with ABC, saying they were still gathering information and stressing the continued importance of social distancing during the ongoing pandemic.

One thing is for sure: Crowded parties are dangerous environments in which you can absolutely catch the coronavirus. A surprise birthday party in Texas infected 18 relatives in June, and a wedding in India caused an outbreak of more than 80 cases one of which, tragically, killed the groom.

This is not political, McKinstry told CNN. This is a public health issue. People are dying and there is no cure. We have to do whatever we can to save as many lives as possible.

Excerpt from:
College Kids Are Apparently Playing a Game Where They Try to Catch COVID - Futurism

A Shot of This Gene Editing Serum Appears to Prevent Heart Disease in Monkeys – Futurism

By adminJuly 3, 2020Stem Cell Doctors

If a new experiment is to be believed, a single gene-editing injection could someday eliminate the risk of heart disease.

Doctors from the biotech company Verve Therapeutics injected 13 monkeys with a serum that shut off two particular genes in their livers responsible for producing cholesterol and triglyceride fats, The New York Times reports. If the same could be accomplished in humans, scientists suspect that for many people, heart disease and fatal heart attacks could become relics of the past.

This could be the cure for heart disease, Dr. Michael Davidson, Lipid Clinic director at the University of Chicago Pritzker School of Medicine, who did not contribute to the research, told the NYT.

The idea would be to inject young people in order to gene-hack them so that they can go about life free of heart disease. Unfortunately for older generations, heart attacks and other conditions can be the result of decades-worth of high cholesterol filling their veins with plaque.

The serum altered the DNA of every cell in the 13 monkeys livers, according to the research, which hasnt yet been peer-reviewed or published but was presented Saturday at the International Society for Stem Cell Researchs annual meeting.

Specifically, it switches off two genes: PCSK9, which regulates LDL cholesterol thats the bad kind and ANGPTL3, which regulates triglycerides, a type of fat that can be stored in the blood.

It will be years before the team can repeat the experiment in humans, the NYT reports, because they need to observe the monkeys for any potential side effects from the gene alteration and to see if the effect is permanent or not.

We hope it will be one-and-done, but we have to validate that with clinical trials, Davidson told the NYT.

Go here to see the original:
A Shot of This Gene Editing Serum Appears to Prevent Heart Disease in Monkeys - Futurism

Katharine McPhee reveals frustrations with husband David Foster in new documentary – Wonderwall

By adminJuly 3, 2020Stem Cell Doctors

Nick Cordero continues to face an uphill battle in his fight with the coronavirus.

After three months of hospitalization, the Broadway star's wife, Amanda Kloots, told CBS on Thursday that he will probably need a double lung transplant.

"We think that that is most likely the possibility. A 99 percent chance that he would be needing that in order to live the kind of life that I know my husband would want to live," she said on CBS This Morning.

But, being a recipient of a transplant is not automatic.

"That is a long road away and a lot of things would have to line up in order for Nick to be a candidate for that," she said.

In mid-May, Nick woke up after being unconscious for about six weeks due to Covid-19 complications.

The Tony-nominated actor has struggled with multiple issues since entering the emergency room on March 30 and being intubated on a ventilator on April 1. Just over three weeks later, he had his right leg amputated after dealing with blood clots. While unconscious, he also suffered two mini strokes, septic shock and fungus in his lungs, among other things, and he needed a temporary pacemaker to assist his heart. In May, Amanda acknowledged that there was "an issue with infection in his lungs." A few weeks later, she said doctors started stem cell treatment to try and repair Nick's lungs.

In the new interview with Gayle King, Amanda, who shares 1-year-old son Elvis with Nick, said she's told her husband that his leg had to be amputated.

"I told him how there's amazing prosthetics. And I told him that I've been talking to amputees and to try to give him encouragement," she said, adding that he's "stable" right now.

"Nick's body is extremely weak," she continued."Muscles have atrophied, so he can't move his body yet He can still open his eyes, and when he is alert and awake, he'll answer commands by looking up or down, yes or no questions."

While Amanda remains hopeful, she knows that it's a "miracle" that Nick is still alive.

"I believe, Gayle, that God is the only person that's going to decide when and if my husband goes. So I will never try to play that role He's fighting. I see it every day. Nick's doctor sees it. And as long as he's in there and fighting, I'll continue to fight with him," she said. "I tell him, I say, 'You're going to walk out of this hospital, honey. I believe it, I know you can We're going to dance again. You're going to hold your son again.' My line is, 'Don't get lost, get focused.'"

More here:
Katharine McPhee reveals frustrations with husband David Foster in new documentary - Wonderwall